Skip to main content
. Author manuscript; available in PMC: 2013 Oct 21.
Published in final edited form as: Genet Med. 2011 Apr;13(4):325–332. doi: 10.1097/GIM.0b013e3182011636

Table 3.

Knowledge about DTC testing

Yes
(%)
No
(%)
Don’t know
(%)
Diseases that can be tested/screened DTC
  Hereditary breast and ovarian cancer 68a 12 20
  Cystic fibrosis 48a 9 43
  Cardiovascular diseaseb 48a 4 48
  Hemochromatosis 46a 1 53
  Alzheimer diseaseb 41a 5 54
  Newborn screening 40a 17 43
  Depressionb 20a 9 70
  Schizophreniab 20 11a 69
True (%) False (%) Don’t know (%)

Oversight and regulation
  DTC genetic testing is currently regulated by the US government 2 77a 21
  NIH has the authority to regulate DTC genetic testing 0 58a 42
  FTC has the authority to regulate DTC genetic testing 47a 0 53
  FDA has authority to regulate DTC genetic testing 21a 30 48
  All DTC genetic testing companies use CLIA approved laboratories 8 50a 42
  Genetic testing offered DTC can be purchased internationally over the Internet 61a 4 36
  DTC genetic testing companies must demonstrate clinical validity and utility before marketing genetic tests DTC 6 67a 27
True (%) False (%) Don’t know (%)

Organizations that have issued a position statement
  American Board of Genetic Counseling (ABGC) 7 34a 59
  American Board of Medical Genetics (ABMG) 5 24a 71
  American College of Medical Genetics (ACMG) 35a 6 59
  American Society of Human Genetics (ASHG) 21a 8 71
  National Society of Genetic Counselors (NSGC) 73a 7 20

NIH, National Institutes of Health; FTC, Federal Trade Commission; FDA, Food and Drug Administration; CLIA, Clinical Laboratory Improvement Amendments.

a

Correct response.

b

Not currently standard of care to offer genetic testing for condition in a clinical setting.